Efficacy of ocaratuzumab (AME-133v) in relapsed follicular lymphoma patients refractory to prior rituximab.
Jennifer L. Wayne
No relevant relationships to disclose
Kristen N. Ganjoo
No relevant relationships to disclose
Brad L. Pohlman
No relevant relationships to disclose
Sven De Vos
No relevant relationships to disclose
Ian W. Flinn
No relevant relationships to disclose
Nam H. Dang
No relevant relationships to disclose
Markus Y. Mapara
No relevant relationships to disclose
Mitchell R. Smith
No relevant relationships to disclose
Adrienne M. O'Reilly
No relevant relationships to disclose
Shashidhara Y. Marulappa
No relevant relationships to disclose
Vinay Kumar Jain
No relevant relationships to disclose